Daporinad

DB12731InvestigationalSmall molecule

Daporinad has been used in trials studying the treatment of Melanoma, Cutaneous T-cell Lymphoma, and B-cell Chronic Lymphocytic Leukemia.

Chemical structure of Daporinad
Mechanism
Curator reviewed
Formula / weight
C24H29N3O2 · 391.515 g/mol (avg)
Code names
APO-866 · FK-866 · K 22.175

Resolves to

Compound
UNIIV71TF6V9M7CAS658084-64-1ChEMBLCHEMBL566757PubChem6914657
Structure
InChIKeyKPBNHDGDUADAGP-VAWYXSNFSA-NSMILESO=C(NCCCCC1CCN(CC1)C(=O)C1=CC=CC=C1)\C=C\C1=CC=CN=C1
Targets
P43490NAMPT

What you can answer from here — as of August 26, 2024

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Daporinad, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In